Fenofibrate has no effect on atherosclerotic progression in patients with type 2 diabetes who are treated for 5 years, although the drug does produce a reduction in levels of low-density lipoprotein cholesterol (LDL-C) compared with placebo.
Read More »Diabetes In Control
Impact of Metformin vs. Repaglinide on Cardiovascular Risk With Type 2’s
Metformin was more effective in reducing selected biomarkers reflecting inflammation and endothelial dysfunction compared with repaglinide.
Read More »4 Steps to Reverse the Damage from Fast Food Diets
Diets high in fast food can be highly toxic to the liver and other internal organs, but that damage can be reversed, says one of the country’s leading experts on non-alcoholic fatty liver disease, who offers four steps to undo the effects of a ‘super-size me’ diet.
Read More »Study Ties Obesity, Inflammatory Proteins to Heart Failure Risk
Heart specialists at Johns Hopkins and elsewhere report what is believed to be the first wide-scale evidence linking severe overweight to prolonged inflammation of heart tissue and the subsequent damage leading to failure of the body’s blood-pumping organ.
Read More »Model Predicts Pill Combination Could Prevent 4.5 Million Deaths
Giving most people with diabetes an inexpensive combination of medications consisting of an ACE, Aspirin, Metformin and a Statin, could dramatically reduce the number of diabetes-related complications and deaths in America and ultimately save money, according to a highly detailed mathematical model developed to simulate human physiology and health care …
Read More »Diabetes Education Reduces Hospitalizations
Diabetes classes or visits to a nutritionist by patients with diabetics are associated with lower hospitalization rates and reductions in medical costs, according to new findings published in Diabetes Care. Having had any type of educational visit was associated with $11,571 less in hospital charges per person,
Read More »Family Physicians Can Successfully Initiate Insulin Therapy
In a randomized trial of patient-titrated insulin glargine with family physicians was compared with standard oral therapy.
Read More »Cheating Destiny: Living with Diabetes
A few weeks ago we had an article by the endocrinologist Irl Hirsch. What many of you may not know is that his brother James, also has diabetes and has written a book about his and other folks experiences with the disease. Leigh Anne Bowen, University of Florida Doctor of …
Read More »Embryonic Stem Cells Become Insulin Producing BetaCells
Embryonic Stem Cells Become Insulin Producing Beta Cells according to the biotechnology company Novocell , and verified by Dr. Camillo Ricordi, Director, Diabetes Research Institute at the University of Miami. Our special reporter Linda Stine, has the inside scoop on this ground breaking work
Read More »Blood Pressure in Diabetic Children Predicts Level Later in Life
Higher blood pressures in childhood correlated with higher levels in young adulthood, European researchers reported In a study of nearly 900 type 1 diabetics.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.